ONB: Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System

Product code ONB, “Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System” in FDA's classification database, is a Class II device type under 21 CFR 880.5440 (intravascular administration set), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 41 clearances under ONB, 41 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
ONB
Regulation
21 CFR 880.5440
Class
II
Panel
General Hospital
Clearances
41
Most recent
Dec 5, 2025
Median review, last 2 years
90 days
Third-party review
Not eligible
Implant
No

What it covers

Reconstitute and transfer antineoplastic and other hazardous drugs in healthcare setting indicated to reduce exposure of healthcare personnel to chemotherapy agents in healthcare setting.

FDA’s definition of product code ONB, from the Product Classification database.

Recent clearances

510(k)DeviceApplicantDecisionType
K251722ProSeal™ Transfer Injector (421120, 421130, 421140)Epic Medical Pte. , Ltd.Dec 5, 2025Special
K253033Chemfort® 28-day 20 mm Vial Adaptor and 13 mm ConvertorSimplivia Healthcare , Ltd.Oct 21, 2025Special
K250059BD PhaSeal™ Optima Connecting Set (C83-O); BD PhaSeal™ Optima Spike Set (C180-O)Becton, Dickinson and CompanySep 12, 2025Traditional
K251411Chemfort Female Luer Lock AdaptorSimplivia Healthcare , Ltd.Aug 5, 2025Traditional
K251340ProSeal™ Bag Spike with Additive Port (423370ST, 423370)Epic Medical Pte. , Ltd.May 29, 2025Special
K243976ZeroClear™ Bag Access (423100)Epic Medical Pte. , Ltd.Jan 22, 2025Special
K240517ProSeal™ Vented Universal Vial AdaptorEpic Medical Pte. , Ltd.Dec 26, 2024Traditional
K241988ProSeal™ Closed System Bag AccessEpic Medical Pte. , Ltd.Oct 23, 2024Traditional
K241735ProSeal™ In Line Pump Set (423850)Epic Medical Pte. , Ltd.Oct 10, 2024Special
K241823ToxiSeal™ Vial AdaptorEpic Medical Pte. , Ltd.Aug 30, 2024Special
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 41 with a free account)

Clearances by year

41 ONB 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2025660
20248102
20233175
20221904
20213277
20203213
20191266
20186249
2017294
20153235
20142154
2013358

Who submits

13 applicants cleared a ONB device since 2011. 39% of the clearances went to applicants in United States, then Singapore (29%), Israel (27%) and China (2%). By type: Traditional 66%, Special 29% and Abbreviated 5%.

ApplicantClearances since 2011
Epic Medical Pte. , Ltd.12
Simplivia Healthcare , Ltd.6
Becton, Dickinson and Company4
Equashield Medical , Ltd.4
Icu Medical, Inc.3
Teva Medical Ltd., Migada Plant3
Becton, Dickinson & CO2
J & J Solutions, Inc. D/B/A/ Corvida Medical2

How FDA classifies it

Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.

From 21 CFR 880.5440. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 880.5440 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent ONB clearances declared.

Ask about ONB

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about ONB

What is FDA product code ONB?

Product code ONB, “Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System” in FDA's classification database, is a Class II device type under 21 CFR 880.5440 (intravascular administration set), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 41 clearances under ONB, 41 of them since 2011.

How many 510(k) clearances are there under ONB?

FDA’s 510(k) database listed 41 clearances under ONB as of Oct 29, 2026, 41 of them decided since 2011; the most recent decision was Dec 5, 2025. The Predicate Finder searches the live database.

How long does FDA take to clear a ONB 510(k)?

For the 7 ONB clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 90 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most ONB clearances?

Since 2011: Epic Medical Pte. , Ltd. (12), Simplivia Healthcare , Ltd. (6), Becton, Dickinson and Company (4), Equashield Medical , Ltd. (4) and Icu Medical, Inc. (3). 13 applicants have cleared a ONB device in that time.

Sources

  1. FDA product classification: ONB · Product Classification database
  2. 21 CFR 880.5440: Intravascular administration set · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for ONB · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow ONBGet an email when FDA clears, recalls or publishes guidance for ONB devices.

Know what FDA already cleared.